Sagimet Biosciences, Inc. (SGMT)
10.80
-0.29
(-2.61%)
USD |
NASDAQ |
Sep 21, 16:00
10.80
0.00 (0.00%)
After-Hours: 20:00
Sagimet Biosciences Total Assets (Quarterly) : 263.43M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 263.43M |
| March 31, 2026 | 107.76M |
| December 31, 2025 | 116.48M |
| September 30, 2025 | 128.40M |
| June 30, 2025 | 137.41M |
| March 31, 2025 | 146.17M |
| December 31, 2024 | 160.26M |
| September 30, 2024 | 174.78M |
| June 30, 2024 | 189.02M |
| March 31, 2024 | 194.53M |
| December 31, 2023 | 96.72M |
| Date | Value |
|---|---|
| September 30, 2023 | 102.92M |
| June 30, 2023 | 21.50M |
| March 31, 2023 | 27.25M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | 77.20M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.275M |
| Shareholders Equity (Quarterly) | 256.16M |
| Debt to Equity Ratio | 0.0076 |
| Current Ratio | 44.94 |
| Net Debt Paydown Yield | -0.08% |